Differences in airway inflammation in cystic fibrosis and primary ciliary dyskinesia

Pediatric Asthma, Allergy and Immunology

Volumn 22, Issue 4, 2009, Pages 163-168

  MacKerness, Kathryn J ^a   Jose, Peter J ^a   Bush, Andrew ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; DNA; ELASTIN; LEUKOCYTE ELASTASE;

ADOLESCENT; AIRWAY; ARTICLE; CELL ISOLATION; CHILD; CILIARY DYSKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DNA CONTENT; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCHOOL CHILD; SPUTUM ANALYSIS;

EID: 77949344928     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.2009.0022     Document Type: Article

References (27)

1. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, Peault B, Puchelle E. Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 2000 ; 23: 121-127 .
2. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999 ; 160: 186-191 .
3. Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R, Uddin J, Guggino WB, Atabani SF, Belkaid Y, Xu Y, Whitsett JA, Accurso FJ, Wills-Karp M, Petasis NA. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol 2004 ; 5: 388-392 .
4. Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, Henson PM. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 2002 ; 109: 661-670 .
5. Smith AL, Redding G, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, Moss R, Ramsey B, Rubio T. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr 1988 ; 112: 547-554 .
6. Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 1995 ; 126: 515-523 .
7. Balfour-Lynn IM. Anti-inflammatory approaches to cystic fibrosis airways disease. Curr Opin Pulm Med 2007 ; 13: 522-528 .
8. Afzelius BA. A human syndrome caused by immotile cilia. Science 1976 ; 193: 317-319 .
9. Zihlif N, Paraskakis E, Lex C, Van de Pohl LA, Bush A. Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia. Pediatr Pulmonol 2005 ; 39: 551-557 .
10. Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, Zariwala MA, Knowles MR. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004 ; 169: 459-467 .
11. Ellerman A, Bisgaard H. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. Eur Respir J 1997 ; 10: 2376-2379 .
12. Sagel SD, Kapsner R, Osberg I, Sontag MK, Accurso FJ. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am J Respir Crit Care Med 2001 ; 164: 1425-1431 .
13. Dean TP, Dai Y, Shute JK, Church MK, Warner JO. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res 1993 ; 34: 159-161 .
14. Richman-Eisenstat JB, Jorens PG, Hebert CA, Ueki I, Nadel JA. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993 ; 264: L413-L418 .
15. Bush A, Payne D, Pike S, Jenkins G, Henke MO, Rubin BK. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest 2006 ; 129: 118-123 .
16. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998 ; 132: 589-595 .
17. Bush A, Cole P, Hariri M, Mackay I, Phillips G, O'Callaghan C, Wilson R, Warner JO. Primary ciliary dyskinesia: diagnosis and standards of care. Eur Respir J 1998 ; 12: 982 - 988 .
18. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995 ; 152: 1107-1136 .
19. Sabroe I, Hartnell A, Jopling LA, Bel S, Ponath PD, Pease JE, Collins PD, Williams TJ. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol 1999 ; 162: 2946-2955 .
20. Evans CA, Garcia HH, Hartnell A, Gilman RH, Jose PJ, Martinez M, Remick DG, Williams TJ, Friedland JS. Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect Immun 1998 ; 66: 4522-4525 .
21. Perks B, Shute JK. DNA and actin bind and inhibit interleukin-8 function in cystic fibrosis sputa: in vitro effects of mucolytics. Am J Respir Crit Care Med 2000 ; 162: 1767-1772 .
22. Suri R, Marshall LJ, Wallis C, Metcalfe C, Bush A, Shute JK. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis. Am J Respir Crit Care Med 2002 ; 166: 352-355 .
23. Bush A, Rubin BK. Macrolides as biological response modifi- ers in cystic fibrosis and bronchiectasis. Semin Respir Crit Care Med 2003 ; 24: 737-748 .
24. Equi A, Balfour-Lynn IM, Bush A, Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002 ; 360: 978-984 .
25. Pukhalsky AL, Kapranov NI, Kalashnikova EA, Shmarina GV, Shabalova LA, Kokarovtseva SN, Pukhalskaya DA, Kashirskaja NJ, Simonova OI. Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. Mediators Inflamm 1999 ; 8: 159-167 .
26. Mackerness KJ, Jenkins GR, Bush A, Jose PJ. Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum. Thorax 2008 ; 63: 614-620 .
27. Attucci S, Gauthier A, Korkmaz B, Delepine P, Martino MF, Saudubray F, Diot P, Gauthier F. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential antiinflammatory drug for treating cystic fibrosis. J Pharmacol Exp Ther 2006 ; 318: 803-809 .